Cartesian Therapeutics Inc. Company Profile
NASDAQ: RNACHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 10:13 AM ET
Cartesian Therapeutics at a glance
Cartesian Therapeutics Inc. (NASDAQ: RNAC) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Frederick, MD. Cartesian Therapeutics is led by Dr. Carsten Brunn Ph.D. and employs about 75 people. The company's shares have traded publicly since 2016.
At a market capitalization of $204.2 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001453687, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Cartesian Therapeutics do?
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, which is in phase 1 trials, an autologous autologous B cell maturation antigen (BCMA) directed mRNA CAR-T to treat patients with multiple myeloma. The company is headquartered in Frederick, Maryland.
Business description based on the company's public filings.
Company information
- Legal name
- Cartesian Therapeutics Inc.
- Ticker
- NASDAQ: RNAC
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Carsten Brunn Ph.D.
- Employees
- 75
- Headquarters
- 7495 New Horizon Way, Frederick, MD, United States
- Phone
- 301 348 8698
- Website
- cartesiantherapeutics.com
- IPO year
- 2016
- Market cap
- $204.22M
- SEC CIK
- 0001453687
- Latest annual report
- 10-K · Mar 9, 2026
Companies similar to Cartesian Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LYELLyell Immunopharma Inc. | 8.30 | -3.04% | $203.39M | vs RNAC |
| ADCTADC Therapeutics SA | 1.56 | +9.89% | $199.16M | vs RNAC |
| TRDAEntrada Therapeutics Inc. | 5.39 | -3.92% | $209.87M | vs RNAC |
| ELDNEledon Pharmaceuticals Inc. | 2.41 | -0.52% | $195.64M | vs RNAC |
| SIONSionna Therapeutics Inc. | 4.77 | -1.04% | $215.37M | vs RNAC |
| NGENNervGen Pharma Corp. | 1.78 | +2.30% | $191.39M | vs RNAC |
| WHWKWhitehawk Therapeutics Inc. | 3.35 | -1.91% | $190.70M | vs RNAC |
| GLSIGreenwich LifeSciences Inc. | 15.02 | -2.43% | $220.40M | vs RNAC |